L&T Realty Properties announces its first land acquisition in NCR micro-market

L&T Realty Properties announces its first land acquisition in NCR micro-market


With development potential of 3.6 million sq. ft approx.

L&T Realty Properties (LTRPL), a wholly owned subsidiary of L&T, operating in the urban-premium and luxury real estate segments across four cities, has recently acquired 100 per cent stake in International Green Scapes (IGSL), Delhi.

The acquisition enables LTRPL to leverage 20 acres of land owned by IGSL in Gurugram, significantly strengthening its real estate development portfolio. Marking LTRPL’s first land acquisition in the NCR micro-market, it offers a development potential of approximately 3.6 million square feet.

Further, during FY 2025-26, LTRPL and L&T Realty Developers Ltd another wholly-owned subsidiary of L&T, have cumulatively completed land acquisitions across Mumbai, Delhi and Bengaluru, having an aggregate development potential of 3 million square feet. The acquisitions have strengthened the development potential over the medium-term. L&T has already embarked on a journey to consolidate all its Realty businesses under a single entity, subject to requisite regulatory approvals. Upon completion of the consolidation process, L&T Realty would emerge as a unified, future-ready entity capable of capitalising on India’s real estate growth.

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Apr 27 2026 | 3:04 PM IST



Source link

L&T Realty Properties announces its first land acquisition in NCR micro-market

Sejal Glass hits the roof after strong Q4 show


Sejal Glass hit the 5% upper circuit at Rs 806.65 after the company reported a sharp surge in earnings for the March quarter.

On a consoldiated basis, net profit rose 198.9% YoY to Rs 11.33 crore in Q4 FY26 from Rs 3.79 crore in Q4 FY25. On a sequential basis, profit jumped 126.1% from Rs 5.01 crore in Q3 FY26.

Revenue from operations climbed 69.5% YoY to Rs 114.55 crore in Q4 FY26 compared with Rs 67.59 crore a year ago. Sequentially, revenue increased 13.6% from Rs 100.81 crore in Q3.

Profit before tax stood at Rs 12.25 crore in Q4 FY26, up 116.05% vs Q3 and 224.1% vs Q4 FY25, reflecting strong operating momentum.

 

At the operating level, total expenditure rose 65.7% YoY to Rs 96.38 crore, broadly in line with revenue growth. Raw material costs surged 71.6% YoY to Rs 68.36 crore, indicating elevated input intensity. Employee expenses increased 79.9% YoY to Rs 13.58 crore.

Depreciation more than doubled, rising 129.2% YoY to Rs 4.47 crore. Interest costs grew 21.4% YoY but declined 15.7% sequentially to Rs 4.83 crore.

For the full year, Sejal Glass reported a robust performance. Net sales rose 62.8% YoY to Rs 396.5 crore in FY26. PBT increased 171.7% to Rs 31.62 crore, while profit after tax jumped 162.2% to Rs 28.74 crore.

Consolidated cash flow also improved materially, with net cash from operating activities turning positive at Rs 51.04 crore in FY26 compared with an outflow of Rs 5.7 crore in FY25.

Sejal Glass is a manufacturer and processor of high-quality architectural, toughened, laminated, and insulated safety glass.



Source link

L&T Realty Properties announces its first land acquisition in NCR micro-market

Avantel slides after Q4 PAT slips 21% YoY to Rs 5 cr


Avantel declined 3.20% to Rs 149.60 after the company reported a 21.5% year-on-year decline in consolidated net profit to Rs 4.77 crore in Q4 FY26, compared with Rs 6.08 crore in Q4 FY25.

Revenue from operations rose 29.6% year-on-year to Rs 63.83 crore in Q4 FY26.

Profit before tax (PBT) stood at Rs 7.32 crore in Q4 FY26, down 13.8% compared with Rs 8.49 crore reported in Q4 FY25.

Total expenses increased 39.6% YoY to Rs 57.61 crore in Q4 FY26. Cost of materials consumed stood at Rs 26.51 crore (up 115% YoY), while employee benefit expenses rose 9.7% YoY to Rs 14.61 crore during the period under review.

 

On a segmental basis, revenue from communications and signal processing products stood at Rs 64.15 crore, registering a 29.28% year-on-year growth. Revenue from the healthcare segment was Rs 0.78 crore, registering a 528% year-on-year surge during the quarter.

Meanwhile, the board has recommended a final dividend of Re 0.20 per equity share of face value Rs 2 each (10%) for FY26, subject to shareholders approval at the ensuing AGM.

Avantel is engaged in the business of designing, developing, and maintaining wireless and satellite communication products, defence electronics, radar systems, and the development of network management software applications for its customers, mainly from the aerospace and defence sectors.



Source link

L&T Realty Properties announces its first land acquisition in NCR micro-market

Sun Pharma surges post deal to acquire US-based pharmaceutical company Organon for $3.99 billion


Sun Pharmaceutical Industries jumped 7.42% to Rs 1740.20 after the company announced the signing of definitive agreement with Organon & Co. for acquiring all outstanding shares of Organon at an enterprise valuation of $11.75 billion.

According to the companys exchange filing, Sun Pharma would acquire 100% of Organons issued and outstanding shares for cash at a price of $14 per share, aggregating to approximately $3.99 billion in total equity value.

The company plans to fund the acquisition through a combination of available cash resources and committed financing from banks. The transaction is expected to close in early 2027.

Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021.

 

Organon has a legacy of deep trust and strong brand equity among HCPs, patients, regulators and other stakeholders. A global leader in womens health, the companys portfolio includes more than 70 products across Womens Health and General Medicines, which includes biosimilars, commercialized across 140 countries, with the U.S., Europe, China, Canada, and Brazil among its largest markets.

This global footprint is supported by six manufacturing facilities across the European Union and emerging markets, reinforcing its scale and reach.

The proposed acquisition of Organon is aligned with Sun Pharmas strategy of growing its Innovative Medicines business. The combined company becomes a stronger player in Established Brands /Branded Generics business. The deal also enables Sun Pharmas entry into biosimilars as a Top-10 global player. Organons portfolio, global footprint and strong stakeholder relationships shall complement Sun Pharmas existing strengths and enhance long term value creation.

The combined entity would be among the top 25 global pharmaceutical companies with combined revenue of $12.4 billion. It would also become a stronger cash generating company with EBITDA and cash flow set to nearly double, supporting deleveraging from post transaction net debt-to-EBITDA of 2.3 times.

The transaction has been approved by the boards of directors of Sun Pharma and Organon and is subject to customary closing conditions, including receipt of required regulatory approvals and approval by Organon stockholders.

Dilip Shanghvi, executive chairman of Sun Pharma, said: Organons portfolio, capabilities and global reach are highly complementary to our own, and we believe that bringing the two organizations together can create a stronger and more diversified platform.

Sun Pharmaceutical Industries is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and active pharmaceutical ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market. It is the largest pharmaceutical company in India.

The company has reported a 16.03% rise in consolidated net profit to Rs 3,368.81 crore on a 13.49% increase in revenue to Rs 15,520.54 crore in Q3 FY26 over Q3 FY25.



Source link

L&T Realty Properties announces its first land acquisition in NCR micro-market

Lodha Developers rises after Q4 PAT jumps 9% YoY to Rs 1,008 cr


Lodha Developers rose 1.36% to Rs 852.40 after the company reported consolidated net profit jumped 9.2% to Rs 1,008.1 crore on an 11.6% increase in revenue from operations to Rs 4,713.5 crore in Q4 FY26 over Q4 FY25.

The companys profit before tax (PBT) climbed 6.5% YoY to Rs 1,263.9 crore in Q4 FY26.

Net debt declined by around Rs 800 crore to Rs 5,377 crore during the quarter, supported by strong collections. Net debt-to-equity stood at 0.23x, below the 0.5x ceiling. The exit cost of debt for Q4 FY26 stood at 7.8%, down 10 basis points sequentially.

On a full-year basis, the companys net profit rose 24% to Rs 3,430.7 crore on a 21% increase in revenue from operations to Rs 16,676.2 crore in FY26 over FY25.

 

During the year, the company added 12 projects with a gross development value (GDV) of around Rs 60,000 crore across MMR, Pune, Bengaluru, and NCR, at 2.4 times its annual guidance. Its entry into the NCR market strengthens its presence in Indias second-largest housing market.

As of April 1, 2026, the company had a saleable GDV of Rs 200,000 crore, excluding township landbank earmarked for development beyond five years. It expects moderation in business development investments over the next 24 months, along with higher free cash flow generation.

The company has signed an MoU with the Government of Maharashtra to develop a green data center park in Palava spanning about 400 acres. It plans to build 1 GW of data center capacity on a built-to-suit basis over around 100 acres, aimed at generating rental income.

The Palava landholding of over 4,000 acres is expected to witness value accretion driven by such initiatives and improved connectivity. The data center, along with retail, warehousing, and select office developments, is expected to scale up annuity income tenfold over the next six years.

Abhishek Lodha, MD & CEO, Lodha Developers, said, We are pleased to deliver record profitability for FY26. Our focus on profitable growth and long-term value creation with low leverage has enabled us to scale up our business significantly over the last few years. What is heartening is that this performance has come through despite multiple geopolitical headwinds in the last 12 months, reaffirming the resilience of housing demand from the top brands. This is the first time that we have achieved more than Rs 20,000 crores of pre-sales for the year, and yet, our market share is only about 3.5% (in value terms) out of the primary housing sales in the top 6 cities in India, indicating a long growth runway ahead.

Meanwhile, the company has recommended a final dividend of Rs 4.25 per equity share of face value Rs 10 each (42.5%) for the financial year ended 31 March 2026. The dividend will be paid to shareholders on the record date to be announced, subject to approval at the forthcoming 31st Annual General Meeting.

Lodha Developers (formerly known as Macrotech Developers) is primarily engaged in the business of real estate development.



Source link

YouTube
Instagram
WhatsApp